![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA OK'S CALYPSO'S TUMOR LOCATION SYSTEM
FDA OK'S CALYPSO'S TUMOR LOCATION SYSTEM
August 9, 2006
Calypso Medical Technologies said Tuesday the U.S. Food and Drug Administration OK'd its 4D Localization System for locating prostate tumors. The device, which utilizes electromagnetic technology with Beacon transponders, is intended to
provide tumor location information in the prostate during radiation therapy.
United
Press International
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct